Q4 2025 QT Imaging Holdings Inc Earnings Call Transcript
Key Points
- QT Imaging Holdings Inc (QTI) exceeded its revenue target for 2025, achieving $18.9 million, surpassing the guidance of $18 million.
- The company successfully expanded its international presence with new distribution partnerships in Saudi Arabia and the United Arab Emirates.
- QTI received FDA 510(k) clearance for an enhanced configuration of its breast imaging scanner, improving diagnostic utility.
- The company achieved a significant milestone with the approval of a new Category 3 CPT code for its 3D breast imaging platform, supporting clinical and commercial advancement.
- QTI strengthened its balance sheet with an $18.2 million oversubscribed private placement, positioning the company for continued growth.
- The gross margin for 2025 declined to 45% from 54% in 2024, primarily due to higher costs associated with contract manufacturing.
- Net loss for 2025 was $21.1 million, a significant increase from the $9 million net loss in 2024.
- The company faced increased operating expenses, including a $3 million rise in compensation and benefits.
- QTI's EBITDA for 2025 was negative $18.3 million, compared to negative $4.3 million in 2024, indicating financial challenges.
- The company is still in the process of obtaining regulatory approvals in various regions, which could delay market expansion.
Welcome to the QT Imaging fourth-quarter 2025 financial results conference call. All participants will be in a listen-only mode. (Operator instructions)
Please also note today's event is being recorded. At this time I would like to turn the floor over to Joddy Kane, please go ahead.
This is Jody Cain with Alliance Advisors IR. Thank you for participating in today's call. Joining me from QT Imaging are Doctor Raluka Danu, Chief Executive Officer, and Jay Jennings, Chief Financial Officer. I would like to remind listeners that comments made during this call by management will include forward-looking statements within the meaning of federal securities laws.
Any statements that are not statements of historical facts should be deemed to be forward-looking statements. Such statements involve known and unknown risks, uncertainties, and other factors that may cause the actual results, performance, or achievements to be materially different from those implied by such statements.
All forward
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
